Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs

Journal of Cellular Biochemistry

Volumn 53, Issue S17G, 1993, Pages 73-79

  Schwartz, Arthur G ^a   Pashko, Laura L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal gland; dehydroepiandrosterone; glucose 6 phosphate dehydrogenase

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRASTERONE;

ADRENAL CORTEX; ANIMAL; CHEMISTRY; MOUSE; PHYSIOLOGY; RAT; REVIEW; SKIN TUMOR;

ADRENAL CORTEX; ANIMAL; ANTINEOPLASTIC AGENTS; GLUCOSEPHOSPHATE DEHYDROGENASE; MICE; PRASTERONE; RATS; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027832353     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.240531114     Document Type: Article

References (43)

1. Dehydroepiandrosterone and structural analogs: A new class of cancer chemopreventive agents
2. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone
3. vy/a) mice by long‐term treatment with dehydroepiandrosterone
4. Inhibition of 7,12‐dimethylbenz(a)anthracene‐ and urethane‐induced lung adenomas in A/J mice by long‐term treatment with dehydroepiandrosterone
5. Inhibition of 1,2‐dimethylhydrazine‐induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone
6. Modifying influence of dehydroepiandrosterone on the development of dihydroxy‐di‐n‐propylnitrosamine‐initiated lesions in the thyroid, lung and liver of F344 rats
7. Phenotypic modulation of hepatocarcinogenesis and reduction in N‐nitroso‐morpholine‐induced hemangiosarcoma and adrenal lesion development in Sprague‐Dawley rats by dehydroepiandrosterone
8. Dehydroepiandrosterone (DHEA) and 3β‐methylandrost‐5‐en‐17‐one: Inhibitors of 7,12‐dimethylbenz(a)anthracene (DMBA)‐initiated and 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA)‐promoted skin papilloma formation in mice
9. Dehydroepiandrosterone and 3β‐methylandrost‐5‐en‐17‐one inhibit 7,12‐dimethylbenz(a)anthracene‐induced skin papillomas and carcinomas in mice
10. vy/a mice by dehydroepiandrosterone
11. Effects of dehydroepiandrosterone (DHEA) on diabetic mice
12. Reduction of atherosclerosis by administration of dehydroepiandrosterone
13. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells
14. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production
15. On the specificity of steroid interaction with mammary gland glucose‐6‐phosphate dehydrogenase
16. − production by human neutrophils
17. Macrophage oxidation of L‐arginine to nitrite and nitrate: Nitric oxide is an intermediate
18. A permealized cell system for studying regulation of aryl hydrocarbon hydroxylase: NADPH as rate‐limiting factor in benzo(a)pyrene metabolism
19. DNA damage and oxygen radical toxicity
20. Protection of a rat tracheal epithelial cell line from paraquat toxicity by inhibition of glucose‐6‐phosphate dehydrogenase
21. 1‐ and 7,12‐dimethylbenz(a)anthracene‐induced cytotoxicity and transformation in cultured cells
22. Modulatory mechanisms of chemical carcinogenesis: The role of the NADPH pool in benzo(a)pyrene activation
23. Dehydroepiandrosterone and 16α‐Br‐epiandrosterone inhibit 12‐O‐tetradecanoylphorbol‐13‐acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes
24. Inhibition of growth of HeLa and WI‐38 cells by dehydroepiandrosterone and its reversal by ribo‐ and deoxyribonucleosides
25. Mechanism of inhibition of growth of 3T3‐L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: Role of glucose‐6‐phosphate dehydrogenase
26. Reversal by ribo‐ and deoxyribonucleosides of dehydroepiandrosterone‐induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation‐selection process of experimental carcinogenesis
27. Inhibition of 12‐O‐tetradecanoylphorbol‐13‐acetate‐promoted skin tumor formation in mice by 16α‐fluoro‐5‐androsten‐17‐one and its reversal by deoxyribonucleosides
28. Dehydroepiandrosterone induces enzymes that permit thermogenesis and decrease metabolic efficiency
29. Nutrition in relation to cancer
30. Nutrition as a modulator of the aging process
31. Inhibition of proteinuria development in aging Sprague Dawley rats and C57BL/6 mice by long‐term treatment with dehydroepiandrosterone
32. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White female mice fed dehydroepiandrosterone
33. Some physiological effects associated with chronic caloric restriction
34. The biological significance of dehydroepiandrosterone
35. Reversal of food restriction‐induced inhibition of mouse skin tumor promotion by adrenalectomy
36. Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis
37. Initiation of precocious sexual maturation in the immature rat treated with dehydroepiandrosterone
38. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side‐effects in mice and rats
39. The effects of oral dehydroepiandrosterone on endocrine‐metabolic parameters in postmenopausal women
40. Hepatocarcinogenicity of dehydroepiandrosterone in the rat
41. Inhibition of 7,12‐dimethylbenzaanthracene‐initiated and 12‐O‐tetradecanoylphorbol‐13‐acetate‐promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs
42. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone
43. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review